Name | Value |
---|---|
Revenues | 278.7M |
Cost of Revenue | 100.0M |
Gross Profit | 178.7M |
Operating Expense | 166.6M |
Operating I/L | 12.1M |
Other Income/Expense | 2.5M |
Interest Income | 0.0M |
Pretax | 14.6M |
Income Tax Expense | 3.6M |
Net Income/Loss | 11.0M |
Penumbra, Inc. is a global medical device company specializing in the design, development, manufacturing, and marketing of a wide range of neurovascular and vascular medical devices. The company's product portfolio includes aspiration-based thrombectomy systems, neurovascular embolization coiling systems, neurovascular access systems, neurosurgical aspiration tools, detachable embolic coil systems, microcatheters, occlusion devices, and immersive computer-based technologies. Penumbra generates revenue through the sale of its medical devices, which are used in various neurovascular and vascular therapies, and are distributed through direct sales organizations and distributors.